Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Astrazeneca Plc

AZN
12.180,00
120,00 (1,00%)
26 Lug 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
26/7/202414:27ALNCNewsIN BRIEF: Astra pushes to get Imfinzi approved for lung..
26/7/202408:00LSEG_RNSAstraZeneca PLC ODAC reviewed Imfinzi in resectable lung..
25/7/202410:37ALNCNewsTOP NEWS: AstraZeneca shares fall despite improved full-year..
25/7/202408:00LSEG_RNSAstraZeneca PLC Half-year Report
15/7/202408:00LSEG_RNSAstraZeneca PLC Acquisition of Amolyt Pharma completed
05/7/202409:36ALNCNewsTOP NEWS: AstraZeneca drug Tagrisso gets EU approval for..
03/7/202410:57ALNCNewsAptamer shares jump as inks agreement with AstraZeneca
01/7/202416:00LSEG_RNSAstraZeneca PLC Total Voting Rights
01/7/202410:13ALNCNewsTOP NEWS: AstraZeneca cancer and Covid drugs recommended for..
01/7/202408:00LSEG_RNSAstraZeneca PLC Lynparza & Imfinzi positive CHMP in..
26/6/202409:40ALNCNewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in..
25/6/202410:05ALNCNewsTOP NEWS: AstraZeneca details mixed findings from cancer..
25/6/202408:05LSEG_RNSAstraZeneca PLC Update on Imfinzi ADJUVANT BR.31 trial
25/6/202408:00LSEG_RNSAstraZeneca PLC Imfinzi improved EFS and OS in bladder..
20/6/202411:56ALNCNewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast..
18/6/202410:33ALNCNewsTOP NEWS: AstraZeneca disappointed by breast cancer drug..
18/6/202408:00LSEG_RNSAstraZeneca PLC Update on CAPItello-290 Phase III trial
17/6/202410:09ALNCNewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer..
17/6/202408:23ALNCNewsIN BRIEF: AstraZeneca gets positive cancer test results for..
17/6/202408:00LSEG_RNSAstraZeneca PLC Imfinzi approved in the US for endometrial..
12/6/202421:56ALNCNewsAstraZeneca's Farxiga approved to treat paediatric type-2..
12/6/202416:00LSEG_RNSAstraZeneca PLC Director/PDMR Shareholding
10/6/202409:30ALNCNewsTOP NEWS: Astra's Tagrisso gets US priority review for lung..
05/6/202410:27ALNCNewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals..
05/6/202408:00LSEG_RNSAstraZeneca PLC Acquisition of Fusion completed
04/6/202413:00PRNUSAbelZeta announces clinical data showing preliminary..
03/6/202416:05LSEG_RNSAstraZeneca PLC Block listing Interim Review
03/6/202416:00LSEG_RNSAstraZeneca PLC Total Voting Rights
03/6/202409:59ALNCNewsAstraZeneca cancer treatment Tagrisso recommended for..
03/6/202408:00LSEG_RNSAstraZeneca PLC Tagrisso plus chemo recommended for approval..
29/5/202409:54ALNCNewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1..
28/5/202422:30GLOBECellectis Reports Financial Results for First Quarter 2024
28/5/202408:00LSEG_RNSAstraZeneca PLC Dato-DXd improved OS in nonsquamous lung..
27/5/202408:49ALNCNewsIN BRIEF: Astra, Daiichi hail positive survival data for..
21/5/202413:18ALNCNewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era..
21/5/202409:18ALNCNewsTOP NEWS: AstraZeneca eyes new era of growth with bold new..
21/5/202408:00LSEG_RNSAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030
20/5/202409:24ALNCNewsTOP NEWS: AstraZeneca plans to build manufacturing plant in..
20/5/202408:00LSEG_RNSAstraZeneca PLC AstraZeneca to manufacture ADCs in Singapore
16/5/202411:27ALNCNewsAstraZeneca trials yield positive results for..
16/5/202408:00LSEG_RNSAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention..
15/5/202416:00LSEG_RNSAstraZeneca PLC Director/PDMR Shareholding
08/5/202410:44ALNCNewsAstraZeneca says withdraws Covid vaccine "for commercial..
07/5/202408:00LSEG_RNSAstraZeneca PLC AstraZeneca completes Cellectis equity..
06/5/202408:46ALNCNewsAstraZeneca completes collaboration and investment deal with..
06/5/202408:00GLOBECellectis Announces Completion of the Additional Equity..
02/5/202411:04ALNCNewsAstraZeneca notes positive trial results for Calquence..
02/5/202408:00LSEG_RNSAstraZeneca PLC Calquence combination improved PFS in 1L MCL
01/5/202416:00LSEG_RNSAstraZeneca PLC Total Voting Rights
29/4/202410:13ALNCNewsAstraZeneca makes progress with Truqap and Enhertu cancer..
Apertura: 12.116,00 Min: 12.114,00 Max: 12.332,00
Chiusura: 12.060,00

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network